ClearPoint Neuro, Inc. (CLPT) Stock

Healthcare · Medical Devices · Member of Other US Stocks

ClearPoint Neuro, Inc. (CLPT) closed at USD 9.24 on 2026-10-14, a change of -65.8 % over the past year, with a market capitalization of USD 294.06M.

ClearPoint Neuro, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

ClearPoint Neuro, Inc. key figures

Previous close

USD 9.24 (2026-10-14)

1-year change

-65.8 %

Market cap

USD 294.06M

Enterprise value

USD 328.64M

P/E ratio (trailing)

-8.69

P/E ratio (forward)

-8.07

EPS (trailing)

-1.11

EPS (forward)

-1.20

PEG ratio

0.61

Price to book

27.31

Revenue growth

18.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.67

Employees

160

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for ClearPoint Neuro, Inc. and compare it with other stocks.